Methods for High-Throughput Drug Combination Screening and Synergy Scoring release_retzz24la5fgnmnfwpriajqmjy

by Liye He, Evgeny Kulesskiy, Jani Saarela, Laura Turunen, Krister Wennerberg, Tero Aittokallio, Jing Tang

Released as a post by Cold Spring Harbor Laboratory.



Gene products or pathways that are aberrantly activated in cancer but not in normal tissue hold great promises for being effective and safe anticancer therapeutic targets. Many targeted drugs have entered clinical trials but so far showed limited efficacy mostly due to variability in treatment responses and often rapidly emerging resistance. Towards more effective treatment options, we will critically need multi-targeted drugs or drug combinations, which selectively inhibit the cancer cells and block distinct escape mechanisms for the cells to become resistant. Functional profiling of drug combinations requires careful experimental design and robust data analysis approaches. At the Institute for Molecular Medicine Finland (FIMM), we have developed an experimental-computational pipeline for high-throughput screening of drug combination effects in cancer cells. The integration of automated screening techniques with advanced synergy scoring tools allows for efficient and reliable detection of synergistic drug interactions within a specific window of concentrations, hence accelerating the identification of potential drug combinations for further confirmatory studies.
In application/xml+jats format

Archived Files and Locations

application/pdf  520.3 kB
file_m45auylo4benvifh5sbqepkt4a (repository) (webarchive)
application/pdf  520.3 kB
file_3at64srt7jf7pewfnvfdkqwevq (webarchive) (web)
application/pdf  519.6 kB
file_ta54fr7x7bbwlishuk4f5ilpoa (webarchive) (web)
Read Archived PDF
Preserved and Accessible
Type  post
Stage   unknown
Date   2016-05-05
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f7d85d8e-850f-4dd9-a4ab-34eac16c09d0